title: Olanzapine for the treatment of acquired neurogenic stuttering.
abstract: Stuttering is a vocal phenomenon, which manifests itself as disturbances in speech fluency. While stuttering is most commonly treated with speech therapy and psychotherapy, a number of antipsychotic agents have been investigated as possible treatments. We present the case of a 37-year-old man who developed a post-concussive syndrome with psychosis and associated stuttering after his second exposure to a blast from an improvised explosive device (IED). After treatment with olanzapine, both his psychosis and his stuttering showed significant improvement. We also discuss stuttering and review previous studies that have investigated antipsychotic use in stuttering.
authors.affiliation: James A Haley Veterans Hospital and University of South Florida College of Medicine, Tampa, USA.
authors.forename: Glenn
authors.initials: G
authors.lastname: Catalano
authors.forename: Derek L
authors.initials: DL
authors.lastname: Robben
authors.forename: Maria C
authors.initials: MC
authors.lastname: Catalano
authors.forename: David A
authors.initials: DA
authors.lastname: Kahn
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D001753:Blast Injuries / Q000150:complications; D001924:Brain Concussion / Q000150:complications; D006801:Humans; D054542:Iraq War, 2003-2011; D008297:Male; D000077152:Olanzapine; D011618:Psychotic Disorders / Q000188:drug therapy / Q000209:etiology; D013342:Stuttering / Q000188:drug therapy* / Q000209:etiology; D014857:Warfare
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine